# NewPro

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/newpro

- Industry: Food
- Headquarters: Shanghai, China
- Latest round: Seed (Dec 23, 2024)
- Investors on record: 1

## About

Established in 2024 and based in Shanghai, China, Xin Yi Cui (Shanghai) Biotechnology Co., Ltd., trading as NewPro, operates as a food additives developer that focuses on the research and development of beverage raw materials and additives. The founder and CEO of the company, Zhe Zeng graduated from Wageningen University and has worked as a scientist at Danone Global Research Center. The core founding team has more than ten years of experience in the research and development of functional food ingredients and industrial microorganisms. In August 2026, NewPro raised a pre-series A funding co-led by Shanghai State-owned Capital Investment Leading Fund and Dalton Venture.

The company mainly develops beverage ingredients and additives. It uses synthetic biology and precision fermentation technologies to develop functional dairy proteins such as lactoferrin, casein, and beta-lactalbumin. Lactoferrin is a protein found in mammalian milk and can be used in infant formula. NewPro is developing sweet protein, an artificial sweetener product.

The company generates revenue by providing beverage ingredients and additives such as Lactoferrin and sweet protein.

The company will use the latest funding to accelerate the compliance application process for its core product, lactoferrin, as a new food ingredient in China; deepening and expanding overseas markets, promote the commercialization of products that have obtained FDA Self-GRAS certification in the international market; and advance the large-scale production capacity construction of functional food proteins.

## Funding rounds

- Seed, Dec 23, 2024 — Linear Capital

## Investors

- Linear Capital (https://capitalatlas.ai/funds/linear-capital) — Seed